Minimisation of unnecessary prescribing of antimicrobials |
13/13 (100) |
21/22 (95.4) |
19/33 (57.5) |
14/14 (100) |
5/6 (83.3) |
72/88 (81.8) |
Timing of antimicrobial administration |
13/13 (100) |
21/22 (95.4) |
19/33 (57.5) |
14/14 (100) |
5/6 (83.3) |
72/88 (81.8) |
Therapeutic drug monitoring |
2/12 (16.6) |
20/22 (90.9) |
13/32 (40.6) |
11/14 (78.5) |
4/6 (66.6) |
50/86 (58.1) |
Need for standard infection prevention and control precautions |
13/13 (100) |
22/22 (100) |
32/33 (96.9) |
12/14 (85.7) |
5/6 (83.3) |
83/88 (94.3) |
Collection of appropriate specimens for microscopy, culture and sensitivity |
9/13 (69.2) |
21/22 (95.4) |
26/33 (78.7) |
12/14 (85.7) |
5/6 (83.3) |
73/88 (82.9) |
Intravenous use only in severely ill patients, unable to tolerate oral treatment, or where oral treatment would not guarantee coverage or tissue penetration |
7/13 (53.8) |
18/22 (81.8) |
14/32 (43.7) |
10/13 (76.9) |
4/6 (66.6) |
53/86 (61.6) |
Review microbiology results daily and de-escalate to pathogen-directed narrow-spectrum treatment promptly |
4/13 (30.7) |
18/22 (81.8) |
10/32 (31.2) |
11/14 (78.5) |
4/6 (66.6) |
47/87 (54.0) |
Review need for intravenous treatment daily and switch to oral route promptly |
3/13 (23.0) |
18/22 (81.8) |
9/32 (28.1) |
10/14 (71.4) |
4/6 (66.6) |
44/87 (50.5) |
Require single dose surgical prophylaxis regimens as appropriate |
5/13 (38.4) |
16/22 (72.7) |
9/32 (28.1) |
9/14 (64.2) |
4/6 (66.6) |
43/87 (49.4) |